Search results for: 'focusing pipelines'

This healthcare market outlook is from the time period 2009 to 2012 and covers the Asia Pacific region as a whole and also South Korea specifically. It goes over the pharmaceuticals, medical devices, clinical diagnostics, medical imaging, life sciences and healthcare IT market segments. Within the coverage of these segments, the presentation also o...

he Vietnamese facilities management (FM) market is expected to record a growth rate of 5.5% in 2019. By 2023, the total market is expected to record a compound annual growth rate (CAGR) of 6.0%, reaching $470.8 million. Rapid growth in Vietnam’s economy is driving building construction in various sectors, such as healthcare, financial, industrial, ...

The infectious disease IVD market in Indonesian presents diversified growth potential for different tiers of participants. Domestic participants stand to gain from the growth momentum in the lower-end market, whereas foreign leading manufacturers dominate the higher-end market. This research service analyses the infectious disease IVD market and p...

The Chinese pharmaceutical market is expected to be the third-largest in the world in 2013. This research service analyzes various aspects of the Chinese pharmaceutical market between 2007 and 2016. Rising income, improving healthcare infrastructure, and insurance systems are some factors that drive this market. The study discusses in detail the ma...

This market insight will highlight key technological developments in the field of agriculture and enabling technologies that will transform the future of agriculture. It will also discuss the main challenges facing farmers, such as depleting water supplies, with a focus on agriculture in Asia-Pacific. Key takeaways from this market insight include ...

With over-4000 pharmaceutical players, China is the second largest pharmaceutical industry globally. Although highly fragmented, global pharma and biopharmaceutical players such as Novartis, Novo Nordisk, and AstraZeneca, have a significant hold capturing at least 8-10Percentage of the market. The market being highly dependent on its distributor ne...

More than 6,000 molecules are currently in clinical development across the pharmaceutical research and development (R&D) landscape, with more than 11,000 in the preclinical phase. The industry is witnessing the growth of small- to mid-segment pharma/biotech players making significant contributions to drug discovery and development pipelines. Across...

This Frost Radar™ examines the Asia-Pacific customer experience (CX) management services landscape, which is a subset of the broader business process outsourcing/management industry. Usually, CX management is a business arrangement in which a company contracts an outside supplier to perform a service rather than accomplishing it in-house. Services ...